SCHEMBL30632497

SCHEMBL30632497

CC(C)C(C(=O)O)c1cc(N2CCC3(CC2)CC(c2ccc4nnc(-c5ccccc5O)cc4c2)C3)no1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26684810 1.00 — —
SCHEMBL26685067 0.92 TACR3 (0.32) —
SCHEMBL30632490 0.92 TACR3 (0.32) —
SCHEMBL30632478 0.87 PBRM1 (0.33) —
SCHEMBL26685136 0.87 PBRM1 (0.33) —
SCHEMBL26683396 0.86 NPC1 (0.30) —
SCHEMBL30666222 0.86 NPC1 (0.30) —
SCHEMBL30632521 0.80 MAPT (0.34) —
SCHEMBL26684930 0.80 MAPT (0.34) —
SCHEMBL30632579 0.79 SMARCA2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119998278-A Compounds and uses thereof 福宏治疗公司 2025-05-13 — — CN disclosed
EP-4522278-A1 BENZOYPARAZINE PYRAZINES ANE THEIR USES Foghorn Therapeutics Inc. (US) 2025-03-19 — — EP disclosed
WO-2023220129-A1 BENZOYPARAZINE PYRAZINES ANE THEIR USES FOGHORN THERAPEUTICS INC. (US) 2023-11-16 — — WO disclosed
Send feedback